Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Hillstream BioPharma (HILS)

Hillstream BioPharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:HILS
DateTimeSourceHeadlineSymbolCompany
22/03/202415:12Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:HILSHillstream BioPharma Inc
22/03/202415:08Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:HILSHillstream BioPharma Inc
21/03/202421:27Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:HILSHillstream BioPharma Inc
21/03/202421:25Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:HILSHillstream BioPharma Inc
25/09/202321:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HILSHillstream BioPharma Inc
21/09/202314:35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNASDAQ:HILSHillstream BioPharma Inc
12/09/202313:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HILSHillstream BioPharma Inc
11/09/202316:51GlobeNewswire Inc.Hillstream Enters into an Exclusive Option Agreement to Acquire a Clinical Stage Asset for Chronic PruritisNASDAQ:HILSHillstream BioPharma Inc
08/09/202319:30GlobeNewswire Inc.Hillstream BioPharma to Present at H.C. Wainwright 25th Annual Global Investment Conference September 11-13NASDAQ:HILSHillstream BioPharma Inc
30/08/202322:22Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:HILSHillstream BioPharma Inc
30/08/202322:20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:HILSHillstream BioPharma Inc
18/08/202322:15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:HILSHillstream BioPharma Inc
11/08/202321:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HILSHillstream BioPharma Inc
09/08/202313:47GlobeNewswire Inc.Hillstream BioPharma to Present at the Sidoti Micro-Cap Virtual Conference on August 16-17, 2023NASDAQ:HILSHillstream BioPharma Inc
20/07/202313:00GlobeNewswire Inc.Hillstream Advances Next-Gen Multispecific Antibodies for Solid Tumors with Lead HER2/HER3 Program, HSB-3215NASDAQ:HILSHillstream BioPharma Inc
17/07/202321:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HILSHillstream BioPharma Inc
11/07/202322:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HILSHillstream BioPharma Inc
10/07/202313:47GlobeNewswire Inc.Hillstream BioPharma Announces Strategic Reprioritization of Pipeline to Targeting HER2/HER3 Solid Tumors via Bispecific and ADC Antibodies and BiologicsNASDAQ:HILSHillstream BioPharma Inc
06/07/202313:30GlobeNewswire Inc.Hillstream BioPharma Licenses Technology to Develop Proprietary HER2 and HER3 Antibody Drug Conjugates against Drug-Resistant Breast, Lung, Gastric, and Ovarian CancersNASDAQ:HILSHillstream BioPharma Inc
20/06/202321:55Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HILSHillstream BioPharma Inc
16/06/202321:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HILSHillstream BioPharma Inc
22/05/202311:01Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:HILSHillstream BioPharma Inc
22/05/202311:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HILSHillstream BioPharma Inc
22/05/202311:01Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HILSHillstream BioPharma Inc
16/05/202321:16Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:HILSHillstream BioPharma Inc
15/05/202321:23Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:HILSHillstream BioPharma Inc
15/05/202321:21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HILSHillstream BioPharma Inc
15/05/202313:47GlobeNewswire Inc.Hillstream BioPharma Strengthens its Board of Directors with Appointment of Kelly AndersonNASDAQ:HILSHillstream BioPharma Inc
02/05/202321:05GlobeNewswire Inc.Hillstream BioPharma Announces Closing of Public Offering of Common StockNASDAQ:HILSHillstream BioPharma Inc
02/05/202313:47GlobeNewswire Inc.Hillstream BioPharma to Present at Upcoming May 2023 Investor and Industry ConferencesNASDAQ:HILSHillstream BioPharma Inc
 Showing the most relevant articles for your search:NASDAQ:HILS